<DOC>
	<DOCNO>NCT02101177</DOCNO>
	<brief_summary>The aim study analyse data come two treatment centre National Treatment Program Centres hepatitis C Egypt</brief_summary>
	<brief_title>Evaluation National Treatment Program Hepatitis C Egypt</brief_title>
	<detailed_description>Analyse data come two centre National Treatment Program hepatitis C Egypt : - 1500 patient start treatment April 1st 2013 March 31st 2014 see week 60 visit July 1st 2014 June 30th 2015 ( Cohort A ) . - 1000 patient recruit July 1st 2014 estimate March 31st 2015 , 200 expect early defaulter contact study team ( Cohort B ) .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<criteria>Age &lt; 18 year &gt; 60 year Positive HCV antibody use third generation test Detectable HCV RNA PCR Liver biopsy show chronic hepatitis either METAVIR score F1 elevate liver enzyme score F2/F3 Naïve treatment PEGIFN RBV HBs antigen negative Prothrombin time ≥60 % , normal bilirubin , alphafoeto protein &lt; 3*normal range laboratory , antinuclear antibody &lt; 1/160 Effective contraception treatment period ; breastfeed Signed informed consent willingness participate study Serious comorbid condition severe hypertension , heart failure , significant coronary heart disease , poorly control diabetes ( HbA1C &gt; 8 % ) , chronic obstructive pulmonary disease Major uncontrolled depressive illness Solid transplant organ ( renal , heart , lung ) Untreated thyroid disease History previous antiHCV therapy Body mass index ( BMI ) great 30 kg/m² Known human immunodeficiency virus ( HIV ) coinfection : although HIV test propose do , patient know HIV coinfection include trial hypersensitivity one two drug ( PEGIFN , RBV ) pregnancy unwilling comply adequate contraception breastfeed neutropenia ( &lt; 1500/mm3 ) anaemia ( &lt; 11g/dL woman ; &lt; 12g/dL men ) thrombocytopenia ( &lt; 100.000/mm3 ) elevate creatinin ( &gt; 1.5mg/dL ) concomitant liver disease hepatitis C ( immunoactive chronic hepatitis B , autoimmune hepatitis , alcoholic liver disease , hemochromatosis , alpha1 antitrypsin deficiency , Wilson disease ) liver biopsy show severe steatosis ( &gt; 66 % ) steatohepatitis ; decompensated cirrhosis ( Child Pugh &gt; A ) ; hepatocellular carcinoma , METAVIR score F4 . TSH &gt; 5 mU/L</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Viral Hepatitis C</keyword>
	<keyword>Genotype 4</keyword>
	<keyword>SVR</keyword>
	<keyword>Egyptian National Program</keyword>
</DOC>